Cargando…
Ferroptosis in osteosarcoma: A promising future
The incidence of osteosarcoma (OS) is increasing year by year, and the prognosis of patients with advanced OS is extremely poor due to the tendency of recurrence and chemotherapy resistance after surgery. Ferroptosis is a novel form of programmed cell death (PCD) that kills cells through iron-depend...
Autores principales: | Liu, Xiang, Du, Shaowen, Wang, Shengdong, Ye, Kaishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705963/ https://www.ncbi.nlm.nih.gov/pubmed/36457488 http://dx.doi.org/10.3389/fonc.2022.1031779 |
Ejemplares similares
-
Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
por: Qiu, Cheng, et al.
Publicado: (2022) -
Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023) -
Ferroptosis in inflammatory arthritis: A promising future
por: Chang, Siyuan, et al.
Publicado: (2022) -
A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
por: Wang, Xinxing, et al.
Publicado: (2022) -
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
por: Wang, Zenan, et al.
Publicado: (2019)